Celltrion Rips Janssen's Bid to Move Up Biosimilar Trial Date
Celltrion slammed Janssen Biotech's recent request for an earlier trial date in its patent infringement dispute over Celltrion's newly approved biosimilar Inflectra, telling a Massachusetts federal judge on Monday that there's...To view the full article, register now.
Already a subscriber? Click here to view full article